Refill data, a rating scale and his own words sit side by side before barriers are sorted by kind in Unit 9 of MN663, for a composite man on oral paliperidone. Searches like "mn 663 unit 9 assignment example", "mn663 unit 9 sample" and "mn663 unit 9 example" land here.
Fifty-Eight Percent of Days Covered: An Adherence Assessment for a 35-Year-Old With Schizoaffective Disorder
[Student Name]
Purdue University Global
MN663: PMHNP Diagnosis and Management Across the Lifespan I
Unit 9 Assignment
[Instructor Name]
[Date]
Composite patient written as a model document. Doses and dates are bracketed; nothing here is a prescribing instruction.
The Discrepancy
A composite 35-year-old man with schizoaffective disorder, bipolar type, has taken oral paliperidone for two years. At this visit he says, "I take it almost every day, maybe miss one here and there." Pharmacy refill records for the last six months show a proportion of days covered of 58 percent, well below the 80 percent often used as a benchmark for adequate adherence. People commonly overestimate their own adherence, and self-report agrees poorly with objective measures in people with schizophrenia (Byerly et al., 2007). The discrepancy is therefore treated as information about how he experiences his medication, not as evidence that he is lying.
The Evidence
Refill records: proportion of days covered, 58 percent over six months, with gaps of two to three weeks in months 2 and 5.
Rating scale: Medication Adherence Rating Scale score of 5 out of 10, with points lost on items about stopping medication when feeling well and taking it only when ill (Thompson et al., 2000).
His account, in his words: "When the voices are loud I take it for sure. When things are quiet I figure I don't need it as much." And: "My schedule is all over the place, so sometimes I just forget."
Why Adherence Matters for Him
Partial adherence is not a small matter in schizoaffective disorder. Both of his hospitalizations followed periods of stopping medication, and in schizophrenia-spectrum disorders, gaps in antipsychotic treatment are among the strongest predictors of relapse. A large meta-analysis comparing long-acting injectable and oral antipsychotics found that injectables were associated with a lower risk of hospitalization or relapse across study designs (Kishimoto et al., 2021). That evidence does not mean he must take an injectable, but it explains why the clinic takes a 58 percent figure seriously and why the option is offered.
Barriers, Classified
Unintentional. His job at a distribution warehouse rotates shifts weekly, so his morning moves by up to six hours. He takes paliperidone in the morning, and on weeks when his morning is 2 p.m., he often forgets. He lives alone in an apartment and has no one to remind him on the days his schedule changes.
Intentional. He believes the medicine matters only when the voices are loud, so he skips it when he feels well. He also dislikes the 9 kg he gained last year, which he attributes to the medication, and admits that he sometimes skips doses "to see if I lose some."
Other contributing factors. He has no side effects he reports as troubling now besides weight. He trusts the clinic and wants to stay out of the hospital, where he was admitted twice before starting paliperidone.
Responses Matched to Barriers
Shifting schedule. Link the dose to a fixed daily event rather than a clock time, such as his first meal after waking, and use a phone alarm tied to that event. Tradeoff: still depends on daily action.
Belief that the medicine is needed only when symptoms are loud. Discuss how paliperidone prevents relapse rather than only treating it, using his own history: both hospitalizations followed periods when he stopped medication. Tradeoff: beliefs change slowly.
Weight. Check his weight, glucose and lipids now and at eight weeks, refer to a nutrition program that meets in the evenings to fit his shifts, and discuss whether the weight gain is related to the medication or to other changes such as diet and activity. Tradeoff: weight loss is slow, and skipping doses is a faster but more dangerous route.
Option of a long-acting injectable. A long-acting injectable form of the same medication, paliperidone palmitate, would remove the need to remember a daily pill and give the clinic a clear record of doses. Tradeoff: a clinic visit each month and an injection, which some people dislike. It is offered as an option he may decline, not as a requirement.
Measuring Adherence Going Forward
Three measures will be repeated at eight weeks: proportion of days covered from refill records, the adherence rating scale and his own estimate of missed doses in the past week. Using the same three sources allows the clinic to see whether the gap between his report and the records narrows, which would suggest the conversation itself changed how he thinks about his medication. A weekly pill organizer will also make missed doses visible to him, which he agreed to try starting this week.
His Sister's Role
With his permission, his sister, who lives nearby and has helped during past relapses, was included in the conversation. She will not supervise his medication, which he does not want, but she agreed to tell the clinic if she notices early warning signs such as withdrawal or poor sleep.
How the Conversation Was Held
The assessment was carried out as a conversation rather than a check. The clinician opened by saying that many people find it hard to take a medicine every day, and that the clinic's job was to understand what makes it hard for him, not to catch him out. The refill numbers were shown to him plainly and he was asked what he made of them. He laughed and said, "I guess I miss more than I thought." That response, rather than a defensive one, is what allowed the discussion of beliefs and weight to follow. The clinician also asked what he liked about the medicine, and he said it keeps him "out of the hospital and at work," which became the anchor for the rest of the plan. Motivational interviewing principles, reflecting his own reasons for taking the medicine and avoiding argument about the ones for skipping it, shaped the tone throughout.
His Choice
He said, "I don't want a shot every month right now, but I'll try the breakfast thing and the alarm, and I'll think about the shot if I end up in the hospital again." That choice is recorded and respected. The plan will be reviewed at eight weeks with refill records and the rating scale repeated. If adherence has improved to 80 percent or more, the plan continues. If it has not, or if he shows early signs of relapse, the long-acting injectable will be raised again, along with the option of a different oral medication with less weight gain.
References
Byerly, M. J., Thompson, A., Carmody, T., Bugno, R., Erwin, T., Kashner, M., & Rush, A. J. (2007). Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatric Services, 58(6), 844-847. https://doi.org/10.1176/ps.2007.58.6.844
Kishimoto, T., Hagi, K., Kurokawa, S., Kane, J. M., & Correll, C. U. (2021). Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: A systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies. The Lancet Psychiatry, 8(5), 387-404. https://doi.org/10.1016/S2215-0366(21)00039-0
Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research, 42(3), 241-247. https://doi.org/10.1016/S0920-9964(99)00130-9
How this MN663 Unit 9 example is structured
The assessment opens on the discrepancy itself and treats it as information rather than dishonesty: people commonly overestimate their own adherence, and the paper cites that finding before examining his case. Evidence precedes interpretation, so the reader sees all three sources before any conclusion is drawn from them. Barriers are then classified, because each class calls for a different response; a reminder system cannot answer a belief, and a conversation about beliefs cannot fix a shifting schedule. Each proposed response is matched to one barrier and carries its tradeoff, for example fewer daily decisions on an injectable set against a clinic visit each month and an injection he may dislike. His sister's role is described with his permission noted. The final part quotes his choice and sets the next measure: refills and the rating scale repeated at eight weeks.
Get an MN663 Unit 9 example written to your instructions
Forward your MN663 Unit 9 case with whatever refill figures, scale scores or patient statements it contains, and the rubric. You will have the first assessment within 24-48h at no charge, with the evidence laid side by side, barriers sorted into forgetting and deciding, and a response matched to each. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
MN663 Unit 9 questions, answered
Which adherence measure should the assessment use?
Ideally more than one, since each has blind spots. Refill records show whether medication was collected, not taken; self-report scales such as the MARS capture attitudes but tend to overestimate; pill counts and drug levels are more objective but intrusive. Name the measures, report their results, and say where they agree and disagree before drawing a conclusion.
Should a long-acting injectable always be offered?
It is often worth raising for someone with repeated partial adherence to an oral antipsychotic, and several guidelines support discussing it. Presenting it as the only answer is the mistake. Describe its advantages and burdens, keep other responses on the table, and record the patient's decision, including a decision to decline, without framing it as noncompliance.
How should the assessment treat someone who says he takes every dose?
Record his account accurately and set it beside the other evidence without calling it false. Overestimating adherence is common and rarely deliberate. Nonjudgmental questions, such as asking how many doses a person misses in a typical week, tend to produce more accurate answers than yes-or-no questions, and the paper can note that approach.